These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11083119)

  • 1. The "rodent carcinogen" dilemma: formidable challenge for the technologies of the new millennium.
    Johnson FM
    Ann N Y Acad Sci; 2000; 919():288-99. PubMed ID: 11083119
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens.
    Goodman G; Shlyakhter A; Wilson R
    Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542
    [No Abstract]   [Full Text] [Related]  

  • 3. Transgenic assays and the identification of carcinogens.
    Tennant R; Haseman J; Stoll RE
    Environ Mol Mutagen; 2001; 37(1):86-92. PubMed ID: 11170246
    [No Abstract]   [Full Text] [Related]  

  • 4. Will all chemicals be carcinogenic to rodents when adequately evaluated?
    Ashby J; Purchase IF
    Mutagenesis; 1993 Nov; 8(6):489-93. PubMed ID: 8133777
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
    French J; Storer RD; Donehower LA
    Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals.
    Prival MJ
    Environ Mol Mutagen; 2001; 37(1):55-69. PubMed ID: 11170242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenesis bioassay results from the National Toxicology Program.
    Huff J
    Environ Health Perspect; 1982 Nov; 45():185-98. PubMed ID: 7140693
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting and predicting the activity of rodent carcinogens.
    Parry JM
    Mutagenesis; 1994 Jan; 9(1):3-5. PubMed ID: 7911554
    [No Abstract]   [Full Text] [Related]  

  • 11. Society of toxicologic pathology position on assessment of hyperplastic lesions in rodent carcinogenicity studies.
    Boorman G; Dixon D; Elwell M; Kerlin R; Morton D; Peters T; Regan K; Sullivan J;
    Toxicol Pathol; 2004; 32(1):124-5. PubMed ID: 14713557
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative activity of 4,4'-diaminobiphenyl (benzidine) and its terphenyl analogue, 4,4'-diaminoterphenyl, in two in vitro assays for potential carcinogenicity.
    Ashby J; Styles J; Callander RD
    Carcinogenesis; 1980 Sep; 1(9):801-2. PubMed ID: 11219872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogens and human health: Part 2.
    Rall DP
    Science; 1991 Jan; 251(4989):10-3. PubMed ID: 1986406
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
    Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism--no synergism--in pairwise tests of carcinogens in rats.
    Gough M
    Regul Toxicol Pharmacol; 2002 Jun; 35(3):383-92. PubMed ID: 12202053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo rodent test systems for assessment of carcinogenic potential.
    van der Laan JW; Spindler P
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):122-5. PubMed ID: 11846641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB6F1-rasH2 mouse: overview of available data.
    Usui T; Mutai M; Hisada S; Takoaka M; Soper KA; McCullough B; Alden C
    Toxicol Pathol; 2001; 29 Suppl():90-108. PubMed ID: 11695565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of human carcinogens in the Salmonella and rodent bone marrow cytogenetic tests.
    Nersessians AK
    Mutat Res; 1992 Apr; 281(4):239-43. PubMed ID: 1373216
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
    Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.